Loading...
Disc Medicine, Inc.
IRON•NASDAQ
Healthcare
Biotechnology
$60.61
$0.03(0.05%)
Disc Medicine, Inc. (IRON) Financial Performance & Income Statement Overview
Review Disc Medicine, Inc.’s income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns.
Revenue Growth
0.00%
Operating Income Growth
-42.35%
↓ 42.35%
Net Income Growth
-43.08%
↓ 43.08%
Operating Cash Flow Growth
-27.86%
↓ 27.86%
Operating Margin
0.00%
Gross Margin
0.00%
Net Profit Margin
0.00%
ROE
-22.61%
↓ 22.61%
ROIC
-20.01%
↓ 20.01%
Disc Medicine, Inc. (IRON) Income Statement & Financial Overview
Review Disc Medicine, Inc.'s (IRON) income statement with detailed quarterly and annual figures.
| Metric | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|
| Revenue | $0.00 | $0.00 | $0.00 | $0.00 |
| Cost of Revenue | $0.00 | $0.00 | $110000.00 | $26000.00 |
| Gross Profit | $0.00 | $0.00 | -$110000.00 | -$26000.00 |
| Gross Profit Ratio | ||||
| R&D Expenses | $24.80M | $24.68M | $23.48M | $23.70M |
| SG&A Expenses | $9.75M | $8.17M | $7.37M | $7.76M |
| Operating Expenses | $34.55M | $32.86M | $30.85M | $31.46M |
| Total Costs & Expenses | $34.55M | $32.86M | $30.85M | $31.46M |
| Interest Income | $5.84M | $6.36M | $4.57M | $4.52M |
| Interest Expense | $572000.00 | $0.00 | $0.00 | $0.00 |
| Depreciation & Amortization | $9000.00 | $11000.00 | $110000.00 | $26000.00 |
| EBITDA | -$13.25M | -$32.84M | -$30.74M | -$31.44M |
| EBITDA Ratio | ||||
| Operating Income | -$34.55M | -$32.86M | -$30.85M | -$31.46M |
| Operating Income Ratio | ||||
| Other Income/Expenses (Net) | $5.27M | $6.37M | $4.56M | $4.52M |
| Income Before Tax | -$29.28M | -$26.48M | -$26.29M | -$26.94M |
| Income Before Tax Ratio | ||||
| Income Tax Expense | $176000.00 | $114000.00 | $60000.00 | $5000.00 |
| Net Income | -$29.46M | -$26.60M | -$26.35M | -$26.95M |
| Net Income Ratio | ||||
| EPS | -$0.98 | -$0.89 | -$1.03 | -$1.09 |
| Diluted EPS | -$0.98 | -$0.89 | -$1.03 | -$1.09 |
| Weighted Avg Shares Outstanding | $29.93M | $29.93M | $25.65M | $24.81M |
| Weighted Avg Shares Outstanding (Diluted) | $29.94M | $29.94M | $25.65M | $24.81M |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan